One tumor (NECC013) exhibited a somatic mutation rate more than ten times the median for the cohort (Fig 1A), and this tumor also contained a pathogenic MSH2 missense mutation (p.G164R) suggesting that defective DNA mismatch repair (MMR) may explain the hypermutation phenotype observed in this tumor sample. The gene discussed is MSH2; the disease is neoplasm.